Update on the metabolic effects of steroidal contraceptives and their relationship to cardiovascular disease risk
- 1 May 1994
- journal article
- review article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 170 (5) , 1528-1536
- https://doi.org/10.1016/s0002-9378(94)05015-5
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Cardiovascular Health and Disease in WomenNew England Journal of Medicine, 1993
- Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein.Journal of Clinical Investigation, 1991
- HIGH DENSITY LIPOPROTEIN CHOLESTEROL AS A PREDICTOR OF CARDIOVASCULAR DISEASE MORTALITY IN MEN AND WOMEN: THE FOLLOW-UP STUDY OF THE LIPID RESEARCH CLINICS PREVALENCE STUDYAmerican Journal of Epidemiology, 1990
- High-Density Lipoprotein — The Clinical Implications of Recent StudiesNew England Journal of Medicine, 1989
- Metabolic risk factors for coronary heart disease in women: Perspective from the Framingham StudyAmerican Heart Journal, 1987
- HÆMOSTATIC, LIPID, AND BLOOD-PRESSURE PROFILES OF WOMEN ON ORAL CONTRACEPTIVES CONTAINING 50 µg OR 30 µg ŒSTROGENThe Lancet, 1977
- VITAMINS AND ORAL CONTRACEPTIVE USEThe Lancet, 1975
- Oral ContraceptivesJAMA, 1967
- SOME EFFECTS OF ORAL CONTRACEPTIVES ON SERUM-LIPID AND LIPOPROTEIN LEVELSThe Lancet, 1966
- SOME EFFECTS OF ORAL CONTRACEPTIVES ON CARBOHYDRATE METABOLISMThe Lancet, 1966